Novavax, Inc. (NASDAQ:NVAX)
| CAPS Rating |
|
|---|---|
| Open | $1.41 |
| Previous Close | $1.41 |
| Daily Range | $1.35 - $1.42 |
| 52-Week Range | $1.13 - $3.50 |
| Market Cap | $155.41M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 531,412 |
| Average Daily Volume | 0 |
How do you think NVAX will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
NVAX Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
NVAX News and Commentary
- 5 Reasons Not to Worry About 2012 – The Motley Fool
- Do the Shorts Know Something You Don't? – The Motley Fool
- Avoid This Biotech Stock – The Motley Fool
- This Just In: Upgrades and Downgrades – The Motley Fool
- Novavax Started At Buy By Ladenburg Thalmann – Blog at The Motley Fool
- EXEL – Why FREE content on the Fool is FREE [and Rich Duprey is a FOOL] – Blog at The Motley Fool
- High Risk – High Reward: NVAX vs. EXEL – Blog at The Motley Fool
- NVAX has the best kind of partner – Blog at The Motley Fool
- NVAX - UN Reports Bird Flu in Asia – Blog at The Motley Fool
- NVAX, AMRN, EXEL and what’s wrong with CAPS – Blog at The Motley Fool
- Wall Street's Wrong About These Stocks – The Motley Fool
- NVAX – Cluster Insider Buys in August – Blog at The Motley Fool
- Speculative Biotechs, Government Contracts, and Zzlangerhans – NVAX, PBTH, & SIGA – Blog at The Motley Fool
- Three Major Indexes All Down Near 3%; Investor Concern Over Economy Grows – NASDAQ
- Mid-Day Update: Stock Slide Continues Amid Concern Over Economy, Employment – NASDAQ
- 9 Small Biotechs Near 52-Week Lows – The Motley Fool
- 7 Health-Care Stocks Insiders Are Buying – The Motley Fool
- The Biggest Gift Biotechs Can Give to Investors – The Motley Fool
- Alternative Vaccine Manufacturers: Novavax and Ibio – SeekingAlpha
- Novavax Has Over 400% Upside Potential – SeekingAlpha

RSS Headlines
Fool UK